title: Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator.
abstract: Endothelial cells (ECs) are key participants in angiogenic processes that characterize tumor growth, wound repair, and inflammatory diseases, such as human rheumatoid arthritis (RA). We and others have shown that EC molecules, such as soluble E-selectin, mediate angiogenesis. Here we describe an EC molecule, Lewisy-6/H-5-2 glycoconjugate (Ley/H), that shares some structural features with the soluble E-selectin ligand, sialyl Lewisx (sialyl Lex). One of the main previously recognized functions of Lewisy is as a blood group glycoconjugate. Here we show that Ley/H is rapidly cytokine inducible, up-regulated in RA synovial tissue, where it is cell-bound, and up-regulated in the soluble form in angiogenic RA compared with nonangiogenic osteoarthritic joint fluid. Soluble Ley/H also has a novel function, for it is a potent angiogenic mediator in both in vitro and in vivo bioassays. These results suggest a novel paradigm of soluble blood group Ags as mediators of angiogenic responses and suggest new targets for therapy of diseases, such as RA, that are characterized by persistent neovascularization.
authors.affiliation: Department of Medicine, Section of Arthritis and Connective Tissue Diseases, Northwestern University Medical School, Chicago, IL 60611, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Halloran
authors.forename: W W
authors.initials: WW
authors.lastname: Carley
authors.forename: P J
authors.initials: PJ
authors.lastname: Polverini
authors.forename: C J
authors.initials: CJ
authors.lastname: Haskell
authors.forename: S
authors.initials: S
authors.lastname: Phan
authors.forename: B J
authors.initials: BJ
authors.lastname: Anderson
authors.forename: J M
authors.initials: JM
authors.lastname: Woods
authors.forename: P L
authors.initials: PL
authors.lastname: Campbell
authors.forename: M V
authors.initials: MV
authors.lastname: Volin
authors.forename: A E
authors.initials: AE
authors.lastname: Bäcker
authors.forename: A E
authors.initials: AE
authors.lastname: Koch
mesh_terms: D000017:ABO Blood-Group System / Q000502:physiology*; D043925:Angiogenesis Inducing Agents / Q000096:biosynthesis / Q000502:physiology*; D000954:Antigens, Surface / Q000096:biosynthesis / Q000378:metabolism; D002240:Carbohydrate Sequence; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D002478:Cells, Cultured; D002630:Chemotactic Factors / Q000502:physiology; D016207:Cytokines / Q000502:physiology*; D010450:Endopeptidases / Q000378:metabolism; D016228:Endothelial Growth Factors / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D006868:Hydrolysis; D007983:Lewis Blood Group Antigens / Q000502:physiology*; D008969:Molecular Sequence Data; D012995:Solubility; D013582:Synovial Fluid / Q000276:immunology / Q000378:metabolism
chemical_list: D000017:ABO Blood-Group System; D043925:Angiogenesis Inducing Agents; D000954:Antigens, Surface; D002630:Chemotactic Factors; D016207:Cytokines; D016228:Endothelial Growth Factors; D007983:Lewis Blood Group Antigens; C094162:Lewis Y antigen; D010450:Endopeptidases